Mitoxantrone Injection, Solution, Concentrate
Product Images NDC 61703-343

10 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Mitoxantrone (NDC 61703-343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mitoxantron 01)

FDA Label Image

Mitoxantron 01a

Mitoxantron 01a
Chemical structure of mitoxantrone dihydrochloride, showing its molecular diagram with hydroxyl groups, ketone groups, and amine side chains containing ethanolamine moieties.*
FDA Label Image

Logo (Mitoxantron 02)

FDA Label Image

Mitoxantron 02a

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
Label for Mitoxantrone Injection, USP concentrate, 2 mg/mL (20 mg/10 mL) in a 10 mL vial. The label states it is for intravenous infusion after dilution, and includes the active ingredient mitoxantrone hydrochloride. It advises that it is a multiple-dose vial with a cytotoxic agent warning, and instructions to dispense an enclosed medication guide. The product is labeled as sterile and Rx only, distributed by Hospira, Inc. Storage instructions specify 2°C to 25°C, and mention that it must be refrigerated and protected from light.*
FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Principal Display Panel (10 mL Vial Carton)
Packaging label for Mitoxantrone Injection, USP concentrate, 20 mg/10 mL (2 mg/mL) vial, manufactured by Hospira, Inc. The label indicates this is a sterile, prescription-only multi-dose vial for intravenous infusion after dilution. It includes cautions such as storage conditions and cytotoxic agent warnings, and lists inactive ingredients along with the active ingredient Mitoxantrone Hydrochloride equivalent to 2 mg of Mitoxantrone free base per mL.*
FDA Label Image

Principal Display Panel (12.5 mL Vial Label)

Principal Display Panel (12.5 mL Vial Label)
Label for Mitoxantrone Injection, USP concentrate, 2 mg/mL strength in a 12.5 mL vial. The label indicates it is for intravenous infusion after dilution, multiple-dose vial, marked as a cytotoxic agent. Distributed by Hospira, Inc. The label includes ingredient content, storage instructions, and a barcode.*
FDA Label Image

Principal Display Panel (12.5 mL Vial Carton)

Principal Display Panel (12.5 mL Vial Carton)
Box packaging label for MitoXANTRONE Injection, USP (concentrate) 2 mg/mL provided in a 25 mg/12.5 mL multiple-dose vial. Label shows product information, storage instructions, and active ingredients. Distributed by Hospira, Inc. The label prominently notes "Cytotoxic Agent" in red at the bottom.*
FDA Label Image

Principal Display Panel (15 mL Vial Label)

Principal Display Panel (15 mL Vial Label)
Label for Mitoxantrone Injection, USP concentrate, 2 mg/mL (total 30 mg in 15 mL vial) by Hospira, Inc. The label indicates sterility and Rx only status, with usage instructions for intravenous infusion after dilution. It includes a statement about the vial being multiple-dose and contains warnings for cytotoxic agent handling. The label also lists inactive ingredients and storage instructions, and shows barcodes and lot/expiration placeholders.*
FDA Label Image

Principal Display Panel (15 mL Vial Carton)

Principal Display Panel (15 mL Vial Carton)
This is the packaging label for Mitoxantrone Injection, USP concentrate, 30 mg per 15 mL (2 mg/mL) in a vial. The label indicates it is a cytotoxic agent with instructions for intravenous infusion after dilution. The product is distributed by Hospira, Inc. The label includes ingredient details and storage instructions, emphasizing no preservatives and the need to not freeze the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.